EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS076-00089 
Organism
Homo sapiens 
Tissue/cell
H1 
Coordinate
chr1:1599910-1601100 
Target genes
Number: 45             
NameEnsembl ID
RP11ENSG00000231702
ISG15ENSG00000187608
AGRNENSG00000188157
MIR429ENSG00000198976
TNFRSF18ENSG00000186891
SDF4ENSG00000078808
B3GALT6ENSG00000176022
FAM132AENSG00000184163
RP5ENSG00000260179
UBE2J2ENSG00000160087
SCNN1DENSG00000162572
PUSL1ENSG00000169972
ACAP3ENSG00000131584
CPSF3LENSG00000127054
GLTPD1ENSG00000224051
TAS1R3ENSG00000169962
DVL1ENSG00000107404
MXRA8ENSG00000162576
AURKAIP1ENSG00000175756
CCNL2ENSG00000221978
RP4ENSG00000224870
MRPL20ENSG00000242485
TMEM88BENSG00000205116
ATAD3CENSG00000215915
ATAD3BENSG00000160072
ATAD3AENSG00000197785
TMEM240ENSG00000205090
AL645728.2ENSG00000215791
SSU72ENSG00000160075
AL645728.1ENSG00000215014
AL645728.3ENSG00000236684
C1orf233ENSG00000228594
MIB2ENSG00000197530
MMP23BENSG00000189409
CDK11BENSG00000248333
SLC35E2BENSG00000189339
CDK11AENSG00000008128
RP1ENSG00000226628
NADKENSG00000008130
GNB1ENSG00000078369
TMEM52ENSG00000178821
GABRDENSG00000187730
PRKCZENSG00000067606
C1orf86ENSG00000162585
SKIENSG00000157933
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Foxd3MA0041.1chr1:1600092-1600104GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr1:1600886-1600898AAACAAACAAAC-6.32
NFAT5MA0606.1chr1:1599947-1599957ATTTTCCATT+6.02
NFATC1MA0624.1chr1:1599947-1599957ATTTTCCATT+6.02
NFATC3MA0625.1chr1:1599947-1599957ATTTTCCATT+6.02
mix-aMA0621.1chr1:1600118-1600129ACTAATTAATT-6.62
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_41278chr1:1600574-1602867Left_Ventricle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr116009931601058
Number: 1             
IDChromosomeStartEnd
GH01I001669chr116005751602867
Enhancer Sequence
CCTATGTGGC AAACAAAAGG GTACTCTATC GGTTTCCATT TTCCATTTAC TAATCATCCA 60
CCAAAAACGC CCAGCGCCAC TCCTGCCCAG AAACTGGGTA AAGCTGCTGC CACTGAGGAC 120
AGCCCTGAAA ATGCCTCGAG CGGACAGCTG GACTGTGCAC TCATCCATTT TCTGTTTTTT 180
TTGTTTGTTT GTTTTTATTA TTTTTTGCAC TAATTAATTT TCACCATGCA GATGCAAATG 240
GACAACAAGC ACATGAAAGA GGCTGAACGT CACCATCATC AGGAAAATGC AACAGAAACC 300
CCAATGCGGG GCCGGGCATG GCCAGTCTGG CCAACACGGT GAAACCTCGT CTCTGCTAAA 360
AACATAAAAA CTAGCCAGGC GTGGTGGTGG GCGCCTGTAA TCCCAGCTAC TCGGGAGGCT 420
GAGGCAGGAC AATCACTTAA ACCCGGGAGG CAGAGGTTGC AGTGAGCTGA GATCGCACCA 480
CTGTACCCCA GCCTGGGCAA CAGAGTGAGA TATCATCTCC AAAAAAAAAA AAAAAAATTA 540
AATATAGAAT TATTATATAA TCCAGCACTT CCACTGCTGG GTATACACGC ACAAGAACTG 600
ATGGCCCTGG CCGGCAACCA CAACTTCCCT GCAGGGAGAA TGGCCAAGTC AGTCAGCCTT 660
GACAGCTAAT GGATTAAAAT CCAGAAAACC GCAATAAGAA CTTGAAACTG CATCTCACAC 720
AGAGAACCCT CTGTGTGGGG GACTCTAGGG AAGTCTACAA ATTGCAGGTC CCAGCTACTT 780
GGGAAGCTGA GGCAGGAGAA TAACTTGAGC CTGGTAGGCA GACTTTGCAG TGAGCAGAGA 840
TCACACCATT GCACTCCAGC CTGGGATACA GAGCGAGACT CTTTATAAAA ATAAAAAAAA 900
AAAGTTTTTC TAATAAAAAA AAGAAATTAA GCTAACCTAA AAGTCATCTC AAGTTGAATG 960
ATGAAGAATC AAAACAAAAC AAACAAACAA TAAACAAAAT AAAAGTCTTC ACACAGAAAT 1020
CTGAGCTGCA AACCCCGAGT GGCTCCCAGG GCAACTCAGC TAAGCAGGAC CCGCAGCGGA 1080
GCTGGGCCCA ACCAGCCAGC ACACGGCCTG GAAACGGAAG TCATTCTGCT CCTGAATCAC 1140
CGGAGAAGGC AGCCCGGCAA GTAAGGACGG GACGCCTGTG TCTGAAACCC 1190